ST
AMED

Spot Trading’s Amedisys AMED Stock Holding History

Spot Trading’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,100
Closed -$611K – 3566
2015
Q3 		$611K Buy
+16,100
New +$679K 0.01% 1911
2013
Q4 		– Sell
-75,700
Closed -$1.3M – 3946
2013
Q3 		$1.3M Buy
+75,700
New +$1.12M 0.01% 1701

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Spot Trading's AMED Position: Q2 2014 in Review

Spot Trading sold out of Amedisys (AMED) in Q2 2014, closing a stake of 48,438 shares — an estimated $721K sold.

Spot Trading first reported a position in AMED in Q2 2013 and held it in 4 quarters. The position peaked at $721K in Q1 2014. 124 funds tracked by Wall St. Rank hold AMED as of Q2 2014.

  • Spot Trading reported no remaining Amedisys position as of Q2 2014 after selling out during the quarter.
  • Spot Trading sold 48,438 Amedisys shares in Q2 2014, an estimated $721K.
  • Spot Trading first reported a position in Amedisys in Q2 2013 and held it in 4 quarters.
  • Spot Trading's Amedisys position peaked at $721K in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Amedisys as of Q2 2014.

Based on Spot Trading's 13F filing for Q2 2014, filed 12 Aug 2014.